Skip to content Skip to sidebar Skip to footer

CASAA to Address TPSAC Regarding Modified Risk Product

 

On January 24-25, 2018, the Tobacco Products Scientific Advisory Committee (TPSAC) will discuss modified risk tobacco product applications (MRTPAs), submitted by Philip Morris Products S.A. for the IQOS Heatsticks systems. TPSAC reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information and recommendations to the Commissioner of Food and Drugs. IQOS is a “heat not burn” technology that will​ ​benefit​ ​the​ ​health​ ​of​ ​the population​ ​as​ ​a​ ​whole.​ As with vapor products and smoke-free tobacco, IQOS does not expose consumers to the greatest source of health risk associated with tobacco: the smoke.

CASAA submitted a comment to TPSAC in support of MRTPA on January 3rd, which can be read in full here. CASAA CEO Alex Clark has been accepted to address the Committee during the public comment period on January 25th. To watch the proceedings live, click the links below. (A free download of Adobe Connect is required to view the live stream.)

Wednesday, January 24th, 8:00 AM – 5:00 PM
https://www.fda.gov/AdvisoryCommittees/Calendar/ucm584231.htm

Thursday, January 25th, 8:00 AM – 3:00 PM (Public comment begins at 8:00 AM)
https://www.fda.gov/AdvisoryCommittees/Calendar/ucm584334.htm